We Take Diagnostics Personally

Decisive Diagnostics has many opportunities for diagnostics licensing and partnering. Working with a team of scientists in Europe, Decisive Diagnostics developed a novel bladder cancer assay that will help make the difficult decisions about the best treatment and monitoring options much easier for patients and their doctors.  View the Bladder Cancer page for more details.

We actively maintain a panel of human cell lines that can be used for ADME assays, aCGH experiments, pharmacogenomics testing and proficiency testing.  All of our cell lines were formerly used to produce the ParagonDx human genomic DNA reference controls.  Contact us about licensing or purchasing our proprietary, fully characterized and immortalized cell lines.

See our licensing page for other opportunities.


  • Bladder Cancer Assay

    Using a key panel of genetic markers, Decisive Diagnostics has developed an assay that can help determine risk of bladder cancer progression in patients with early stage disease.
    Read More
    »

  • Immortalized Cell Lines

    From warfarin dosing to Plavix resistance and beyond, we have the immortalized human cell lines you need for pharmacogenomic testing, ADME assays, aCGH studies and other assays requiring DNA controls.
    Read More
    »

  • Additional Licensing Opportunities

    Decisive Diagnostics has the rights to significant intellectual property in areas ranging from sequencing to antibody technology.
    Read More
    »

this is decisivedx2

Comments are closed.